Company Quick10K Filing
Medixall Group
Price-0.00 EPS-0
Shares75 P/E0
MCap-0 P/FCF0
Net Debt-0 EBIT-2
TEV-0 TEV/EBIT0
TTM 2019-09-30, in MM, except price, ratios
10-K 2020-12-31 Filed 2021-06-17
10-Q 2020-09-30 Filed 2020-11-17
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-16
10-K 2019-12-31 Filed 2020-05-14
S-1 2019-11-05 Public Filing
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-30
10-K 2018-12-31 Filed 2019-05-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-06-29
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-03-30
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-28
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-30
10-Q 2014-09-30 Filed 2014-12-01
8-K 2020-07-27
8-K 2020-06-24
8-K 2020-05-14
8-K 2018-06-01
8-K 2018-05-09
8-K 2018-03-07

MDXL 10K Annual Report

Medixall Group Earnings 2020-12-31

Balance SheetIncome StatementCash Flow
0.90.50.1-0.4-0.8-1.22013201520172020
Assets, Equity
0.1-0.1-0.4-0.6-0.9-1.12013201520172020
Rev, G Profit, Net Income
0.80.50.2-0.2-0.5-0.82013201520172020
Ops, Inv, Fin